BRAFV600E-mutated Ovarian Serous Borderline Tumors Are at Relatively Low Risk for Progression to Serous Carcinoma

Oncotarget - United States
doi 10.18632/oncotarget.27326
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC


Related search